rodgers is the director of the national institute of diabetes and digestive and kidney diseases one of the 27 institutes that make up the united states national institutes of health he is also the chief of the institute s molecular and clinical hematology branch and is known for contributions to research and therapy for sickle cell anemia rodgers attended brown university for his undergraduate graduate and medical degrees and holds an mba from johns hopkins carey business school he is a hematologist who has been board certified in internal medicine emergency medicine and hematology rodgers first joined the nih in 1984 he became the chief of the molecular and clinical hematology branch in 1998 and the niddk deputy director in 2001 in 2006 he assumed the directorship on an acting basis and this position was made permanent in 2007 by the nih s director at the time elias zerhouni rodgers is a physician scientist who studies diseases of bone marrow and is best known for his work on the molecular genetics of hemoglobinopathies and on developing a treatment for sickle cell anemia he was a major contributor to the development of hydroxyurea therapy which was approved by the fda in